• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化和比较一组三嗪基取代苯磺酰胺氨基酸缀合物的合成方法。

Optimization and Comparison of Synthetic Procedures for a Group of Triazinyl-Substituted Benzene-Sulfonamide Conjugates with Amino Acids.

机构信息

Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia.

Toxicological and Antidoping Center, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, SK-832 32 Bratislava, Slovakia.

出版信息

Molecules. 2017 Sep 13;22(9):1533. doi: 10.3390/molecules22091533.

DOI:10.3390/molecules22091533
PMID:28902167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6151714/
Abstract

Sulfonamides incorporating 1,3,5-triazine moieties can selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII, and XIV over cytosolic isoforms I and II. In the present work, a highly effective synthetic procedure was proposed for this group of potent cancerostatic drugs and compared with previously used methods. The synthesis of triazinyl-substituted benzene-sulfonamide conjugates with amino acids can be easily carried out using sodium carbonate-based water solution as a synthetic medium instead of -Diisopropylethylamine/Dimethylformamide. The benefits of this synthetic procedure include: (i) high selectivity of the creation of disubstituted conjugates; (ii) several times higher yield (≥95%) than that achieved previously; (iii) elimination of organic solvents by the use of an environmental friendly water medium (green chemistry); (iv) simple and fast isolation of the product. The synthesis and resulting products were evaluated using TLC, IR, NMR, and MS methods. The present work demonstrates a significant advantage in providing shortened routes to target structures.

摘要

含 1,3,5-三嗪部分的磺胺类药物可以选择性和有效地抑制碳酸酐酶跨膜同工酶 IX、XII 和 XIV,而对胞质同工酶 I 和 II 则没有作用。在本工作中,提出了一种针对这组强效抗癌药物的高效合成方法,并与以前使用的方法进行了比较。使用基于碳酸钠的水溶液作为合成介质而不是二异丙基乙胺/二甲基甲酰胺,可以很容易地进行三嗪取代的苯磺酰胺与氨基酸的偶联合成。这种合成方法的优点包括:(i) 二取代偶联物的高选择性;(ii) 收率比以前提高了几倍(≥95%);(iii) 通过使用环保的水介质(绿色化学)消除有机溶剂;(iv) 产物的简单快速分离。采用 TLC、IR、NMR 和 MS 方法对合成和所得产物进行了评价。本工作表明,在提供目标结构的短路线方面具有显著优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/7718ea426b79/molecules-22-01533-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/6df276d0340e/molecules-22-01533-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/4d9faccfc781/molecules-22-01533-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/06e3f088bf61/molecules-22-01533-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/3f571a082aa7/molecules-22-01533-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/511c5e183270/molecules-22-01533-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/7718ea426b79/molecules-22-01533-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/6df276d0340e/molecules-22-01533-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/4d9faccfc781/molecules-22-01533-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/06e3f088bf61/molecules-22-01533-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/3f571a082aa7/molecules-22-01533-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/511c5e183270/molecules-22-01533-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832a/6151714/7718ea426b79/molecules-22-01533-sch006.jpg

相似文献

1
Optimization and Comparison of Synthetic Procedures for a Group of Triazinyl-Substituted Benzene-Sulfonamide Conjugates with Amino Acids.优化和比较一组三嗪基取代苯磺酰胺氨基酸缀合物的合成方法。
Molecules. 2017 Sep 13;22(9):1533. doi: 10.3390/molecules22091533.
2
Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties.含氟和 1,3,5-三嗪基团的磺胺类化合物对人碳酸酐酶同工酶 I-XIV 的抑制作用。
Bioorg Med Chem. 2013 Nov 15;21(22):6929-36. doi: 10.1016/j.bmc.2013.09.031. Epub 2013 Sep 19.
3
Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.含有1,3,5-三嗪基部分的取代苯磺酰胺能有效抑制人碳酸酐酶II、IX和XII。
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1310-4. doi: 10.1016/j.bmcl.2014.01.048. Epub 2014 Jan 27.
4
Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.含 1,3,5-三嗪部分的磺胺类药物选择性和有效地抑制碳酸酐酶跨膜同工型 IX、XII 和 XIV 与胞质同工型 I 和 II:溶液和 X 射线晶体学研究。
Bioorg Med Chem. 2011 May 15;19(10):3105-19. doi: 10.1016/j.bmc.2011.04.005. Epub 2011 Apr 6.
5
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties.含4,4,4-三氟-3-氧代-丁-1-烯基、苯甲酰基硫脲和咪唑-2(3H)-酮/硫酮部分的4-N,N-二取代磺胺的合成及碳酸酐酶I、II、IX和XII抑制研究
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1776-9. doi: 10.1016/j.bmcl.2014.02.030. Epub 2014 Feb 21.
6
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.碳酸酐酶抑制剂:新型磺酰胺类化合物,包含1,3,5-三嗪部分,作为胞质和肿瘤相关碳酸酐酶同工酶I、II和IX的抑制剂。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3102-8. doi: 10.1016/j.bmcl.2005.04.056.
7
Synthesis and carbonic anhydrase I, II, IV and XII inhibitory properties of N-protected amino acid - sulfonamide conjugates.N-保护氨基酸-磺酰胺缀合物的合成及其对碳酸酐酶I、II、IV和XII的抑制特性
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1476-83. doi: 10.3109/14756366.2016.1147438. Epub 2016 Feb 21.
8
New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII.新型含氨基酸部分的磺酰胺类化合物可作为有效且选择性的肿瘤相关碳酸酐酶 XII 的抑制剂。
J Enzyme Inhib Med Chem. 2015 Jun;30(3):430-4. doi: 10.3109/14756366.2014.942659. Epub 2014 Aug 4.
9
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.碳酸酐酶抑制剂:含1,2,4-三嗪部分的磺酰胺类化合物对胞质/肿瘤相关碳酸酐酶同工酶I、II和IX的合成及抑制作用
Bioorg Med Chem Lett. 2004 Nov 1;14(21):5427-33. doi: 10.1016/j.bmcl.2004.07.087.
10
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.碳酸酐酶抑制剂。卤代磺胺和卤代苯基氨基苯甲酰胺衍生物对肿瘤相关同工酶IX的抑制作用。
J Med Chem. 2003 May 22;46(11):2187-96. doi: 10.1021/jm021123s.

引用本文的文献

1
Multicomponent Molecular Systems Based on Porphyrins, 1,3,5-Triazine and Carboranes: Synthesis and Characterization.基于卟啉、1,3,5-三嗪和碳硼烷的多组分分子体系:合成与表征。
Molecules. 2022 Sep 21;27(19):6200. doi: 10.3390/molecules27196200.
2
Synthesis and Inhibition Activity Study of Triazinyl-Substituted Amino(alkyl)-benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Human Carbonic Anhydrases I, II, IV, IX, and XII.三嗪基取代的氨基酸(烷)基苯磺酰胺化合物的合成及其抑制活性研究,其中包含极性和疏水性氨基酸作为人碳酸酐酶 I、II、IV、IX 和 XII 的抑制剂。
Int J Mol Sci. 2021 Oct 19;22(20):11283. doi: 10.3390/ijms222011283.
3

本文引用的文献

1
Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.含有1,3,5-三嗪基部分的取代苯磺酰胺能有效抑制人碳酸酐酶II、IX和XII。
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1310-4. doi: 10.1016/j.bmcl.2014.01.048. Epub 2014 Jan 27.
2
Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties.含氟和 1,3,5-三嗪基团的磺胺类化合物对人碳酸酐酶同工酶 I-XIV 的抑制作用。
Bioorg Med Chem. 2013 Nov 15;21(22):6929-36. doi: 10.1016/j.bmc.2013.09.031. Epub 2013 Sep 19.
3
Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Synthetic Strategies and Computational Inhibition Activity Study for Triazinyl-Substituted Benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Carbonic Anhydrases.
三嗪基取代苯磺酰胺类化合物的合成策略及极性和疏水性氨基酸偶联物作为碳酸酐酶抑制剂的计算抑制活性研究。
Int J Mol Sci. 2020 May 22;21(10):3661. doi: 10.3390/ijms21103661.
4
Special Issue: Sulfonamides.特刊:磺胺类药物。
Molecules. 2017 Sep 29;22(10):1642. doi: 10.3390/molecules22101642.
含 1,3,5-三嗪部分的磺胺类药物选择性和有效地抑制碳酸酐酶跨膜同工型 IX、XII 和 XIV 与胞质同工型 I 和 II:溶液和 X 射线晶体学研究。
Bioorg Med Chem. 2011 May 15;19(10):3105-19. doi: 10.1016/j.bmc.2011.04.005. Epub 2011 Apr 6.
4
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.碳酸酐酶抑制剂:新型磺酰胺类化合物,包含1,3,5-三嗪部分,作为胞质和肿瘤相关碳酸酐酶同工酶I、II和IX的抑制剂。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3102-8. doi: 10.1016/j.bmcl.2005.04.056.
5
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.碳酸酐酶抑制剂:4-异硫氰酸苯甲酰胺衍生的磺酰胺类化合物对胞质/肿瘤相关碳酸酐酶同工酶I、II和IX的合成及抑制作用
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80. doi: 10.1016/j.bmcl.2004.09.062.
6
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.碳酸酐酶抑制剂:含1,2,4-三嗪部分的磺酰胺类化合物对胞质/肿瘤相关碳酸酐酶同工酶I、II和IX的合成及抑制作用
Bioorg Med Chem Lett. 2004 Nov 1;14(21):5427-33. doi: 10.1016/j.bmcl.2004.07.087.
7
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.碳酸酐酶抑制剂:用芳香族和杂环磺胺类药物抑制肿瘤相关同工酶IX。
Bioorg Med Chem Lett. 2003 Mar 24;13(6):1005-9. doi: 10.1016/s0960-894x(03)00091-x.